Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN110105305A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110105305A enables green synthesis of 1,2-benzothiazine derivatives using ionic liquids, offering cost reduction and supply chain reliability for pharmaceutical intermediates.